GLAXOSMITHKLINE: Boniva Patent Infringement Actions Ongoing
April 20, 2009
Roche Laboratories’ Boniva patent infringement actions against several generic drug manufacturers are ongoing, according to GlaxoSmithKline Plc’s Form 20-F filed with the U.S. Securities and Exchange Commission on March 4,…